Breaking News Instant updates and real-time market news.

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

17:29
10/15/18
10/15
17:29
10/15/18
17:29

Edwards Lifesciences initiated with an Underweight at Barclays

Barclays analyst Kristen Stewart initiated Edwards Lifesciences with an Underweight rating and $143 price target.

  • 23

    Oct

EW Edwards Lifesciences
$141.95

-1.44 (-1.00%)

10/15/18
LEHM
10/15/18
INITIATION
Target $143
LEHM
Underweight
Edwards Lifesciences initiated with an Underweight at Barclays
Target $143.
10/09/18
SBSH
10/09/18
NO CHANGE
SBSH
Citi more selective on Medical Device stocks into Q3 results
Citi analyst Amit Hazan is "much more selective than usual" on Medical Device stocks into the Q3 earnings season. While easier comps should bring "strong and stable" Q3 organic sales growth, recent currency volatility will limit both earnings upside and guidance raises, Hazan tells investors in a research note. He sees only Boston Scientific (BSX) and Intuitive Surgical (ISRG) shares moving higher on earnings reports. The analyst expects volatility in both Becton Dickinson (BDX) and Varian Medical (VAR), but would be an "aggressive" buyer of the stocks on any post-earnings weakness. Hazan is also more cautious on names like Edwards Lifesciences (EW), Baxter (BAX), and Zimmer Biomet (ZBH) into the Q3 prints.
10/09/18
ADAM
10/09/18
NO CHANGE
Target $177
ADAM
Buy
Edwards Lifesciences weakness a buying opportunity, says Canaccord
Canaccord analyst Jason Mills said the recent weakness in Edwards Lifesciences is a compelling buying opportunity. The analyst said it remains his top large-cap stock, which enjoys a favorable setup through the Partner 3 low-risk data in March 2019. He also noted the positive data release on the CENTERA U.S. pivotal trial as well as its positioning and strategy in the TAVR space. Mills reiterated his Buy rating and $177 price target on Edwards Lifesciences shares.
10/02/18
BOFA
10/02/18
DOWNGRADE
Target $180
BOFA
Neutral
Edwards Lifesciences downgraded to Neutral from Buy at BofA/Merrill
BofA Merrill Lynch analyst Bob Hopkins downgraded Edwards Lifesciences to Neutral from Buy, primarily due to valuation. Only aggressive assumptions about TAVR market growth and Mitral would suggest real upside to consensus estimates, Hopkins tells investors. Additionally, it remains his view that Edwards is more likely than not to remain independent, added Hopkins, who raised his price target on the stock to $180 from $170 to account for higher valuations in the medical technology sector.

TODAY'S FREE FLY STORIES

KPLUF

K+S

$0.00

(0.00%)

05:34
10/14/19
10/14
05:34
10/14/19
05:34
Downgrade
K+S rating change  »

K+S downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVACF

Avance Gas

$0.00

(0.00%)

05:32
10/14/19
10/14
05:32
10/14/19
05:32
Upgrade
Avance Gas rating change  »

Avance Gas upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPG

Dorian LPG

$11.48

0.22 (1.95%)

05:30
10/14/19
10/14
05:30
10/14/19
05:30
Upgrade
Dorian LPG rating change  »

Dorian LPG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$43.58

(0.00%)

, PFE

Pfizer

$36.11

0.31 (0.87%)

05:25
10/14/19
10/14
05:25
10/14/19
05:25
Hot Stocks
AstraZeneca, Pfizer, Takeda Pharmaceutical enter collaboration with ImaginAb »

ImaginAb announced the…

AZN

AstraZeneca

$43.58

(0.00%)

PFE

Pfizer

$36.11

0.31 (0.87%)

TAK

Takeda Pharmaceutical

$17.29

0.21 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

GS

Goldman Sachs

$204.70

4.85 (2.43%)

, MS

Morgan Stanley

$41.94

0.92 (2.24%)

05:22
10/14/19
10/14
05:22
10/14/19
05:22
Recommendations
Goldman Sachs, Morgan Stanley, E-Trade analyst commentary  »

Hard for Goldman, Morgan…

GS

Goldman Sachs

$204.70

4.85 (2.43%)

MS

Morgan Stanley

$41.94

0.92 (2.24%)

ETFC

E-Trade

$39.49

0.53 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 10

    Nov

  • 12

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:21
10/14/19
10/14
05:21
10/14/19
05:21
Hot Stocks
Genentech says Phase III PEMPHIX study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 06

    Nov

INCY

Incyte

$76.14

0.38 (0.50%)

05:16
10/14/19
10/14
05:16
10/14/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte data enchances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

MELI

MercadoLibre

$554.23

11.5 (2.12%)

05:11
10/14/19
10/14
05:11
10/14/19
05:11
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 17

    Dec

PLNT

Planet Fitness

$58.63

0.94 (1.63%)

05:09
10/14/19
10/14
05:09
10/14/19
05:09
Upgrade
Planet Fitness rating change  »

Planet Fitness upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:06
10/14/19
10/14
05:06
10/14/19
05:06
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

05:05
10/14/19
10/14
05:05
10/14/19
05:05
Upgrade
LeMaitre rating change  »

LeMaitre upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

05:03
10/14/19
10/14
05:03
10/14/19
05:03
Initiation
IGM Biosciences initiated  »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:01
10/14/19
10/14
05:01
10/14/19
05:01
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PING

Ping Identity

$16.47

0.45 (2.81%)

04:58
10/14/19
10/14
04:58
10/14/19
04:58
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

04:57
10/14/19
10/14
04:57
10/14/19
04:57
Initiation
Envista initiated  »

Envista initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$124.41

0.98 (0.79%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

ZLAB

Zai Lab

$32.38

0.01 (0.03%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Zai Lab participates in a conference call with JPMorgan »

SMid Biotechnology Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

SAN

Banco Santander

$4.10

0.155 (3.93%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Banco Santander management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Evercore REITs analyst to hold a luncheon »

REITs Analyst Sakwa holds…

WORK

Slack Technologies

$25.99

2.215 (9.32%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Slack Technologies management to meet with »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

MDLA

Medallia

$29.47

1.365 (4.86%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Medallia management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

CRNCY

Cairn Energy

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Cairn Energy management to meet with Bergenberg »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.